(Q37410888)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

HPV vaccination: the beginning of the end of cervical cancer? - A Review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

main subject

cervix uterine cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Tatiana Rabachini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Luisa Lina Villa

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

1 reference

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

Memórias do Instituto Oswaldo Cruz

23 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

1-10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

Molecular approaches to cervical cancer therapy

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus vaccines and the potential for cross-protection between related HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus vaccines: an update for gynecologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Down-regulation of transforming growth factor-beta type II receptor (TGF-betaRII) protein and mRNA expression in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Case-control study of human papillomavirus and oropharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Results of the first WHO international collaborative study on the standardization of the detection of antibodies to human papillomaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Prime-boost vaccination strategy in women with high-grade, noncervical anogenital intraepithelial neoplasia: clinical results from a multicenter phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors im

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-ba

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

What is needed for effective antitumor immunotherapy? Lessons learned using Listeria monocytogenes as a live vector for HPV-associated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans after in vitro vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Role of IL-2 secreted by PADRE-specific CD4+ T cells in enhancing E7-specific CD8+ T-cell immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Epidemiology of Genital Human Papillomavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Chapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Cancer immunotherapy by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Chimeric papillomavirus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Emerging concepts in CD8(+) T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Monitoring HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

HPV: from infection to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Nonreplicating vaccinia vector efficiently expresses recombinant genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Human papillomavirus (HPV) in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

TGF-beta and regulatory T cell in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Early phase in the infection of cultured cells with papillomavirus virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762009000100001

10.1590/S0074-02762009000100001

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19274369%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference